Merck Net Interest Income from 2010 to 2026

6MK Stock  EUR 103.20  0.20  0.19%   
Merck's Net Interest Income is decreasing over the years with slightly volatile fluctuation. Net Interest Income is expected to dwindle to about -808.9 M. Net Interest Income is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. View All Fundamentals
 
Net Interest Income  
First Reported
2010-12-31
Previous Quarter
-770.4 M
Current Value
-808.9 M
Quarterly Volatility
185.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Merck financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merck's main balance sheet or income statement drivers, such as Tax Provision of 2.1 B, Interest Income of 239.5 M or Interest Expense of 1 B, as well as many indicators such as . Merck financial statements analysis is a perfect complement when working with Merck Valuation or Volatility modules.
  
This module can also supplement various Merck Technical models . Check out the analysis of Merck Correlation against competitors.
Analyzing Merck's Net Interest Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Interest Income has evolved provides context for assessing Merck's current valuation and future prospects.

Latest Merck's Net Interest Income Growth Pattern

Below is the plot of the Net Interest Income of Merck Co over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Merck's Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Merck's overall financial position and show how it may be relating to other accounts over time.
Net Interest Income10 Years Trend
Slightly volatile
   Net Interest Income   
       Timeline  

Merck Net Interest Income Regression Statistics

Arithmetic Mean(596,901,176)
Coefficient Of Variation(31.05)
Mean Deviation177,777,716
Median(429,000,000)
Standard Deviation185,341,658
Sample Variance34351.5T
Range427M
R-Value(0.89)
Mean Square Error7919.6T
R-Squared0.78
Slope(32,495,490)
Total Sum of Squares549624.5T

Merck Net Interest Income History

2026-808.9 M
2025-770.4 M
2024-856 M
2023-781 M
2022-805 M
2021-770 M
2020-772 M

About Merck Financial Statements

Merck stakeholders use historical fundamental indicators, such as Merck's Net Interest Income, to determine how well the company is positioned to perform in the future. Although Merck investors may analyze each financial statement separately, they are all interrelated. For example, changes in Merck's assets and liabilities are reflected in the revenues and expenses on Merck's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Merck Co. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Interest Income-770.4 M-808.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Merck Stock

Merck financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck security.